Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 209 Neoplasms 119 Breast Neoplasms 113 Colorectal Neoplasms 100 Prostatic Neoplasms 80 Ovarian Neoplasms 79 Neoplasm Metastasis 79 Lung Neoplasms 70 Multiple Myeloma 67 Squamous Cell Carcinoma of Head and Neck 51 Pancreatic Neoplasms 50 Endometrial Neoplasms 50 Recurrence 48 Stomach Neoplasms 41 Melanoma 41 Leukemia, Lymphocytic, Chronic, B-Cell 41 Carcinoma, Renal Cell 40 Small Cell Lung Carcinoma 39 Leukemia, Myeloid, Acute 35 Urinary Bladder Neoplasms 32 Lymphoma, Non-Hodgkin 32 Parkinson Disease 4, Autosomal Dominant Lewy Body 30 Triple Negative Breast Neoplasms 29 Carcinoma, Hepatocellular 28 Head and Neck Neoplasms 27 Advanced Solid Tumors 27 Lymphoma, Large B-Cell, Diffuse 26 Lymphoma, Follicular 25 Esophageal Neoplasms 24 Lymphoma 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colitis, Ulcerative × 30 days × Clear all

NCT02808780 2026-06-05

OPAL

Janssen Biotech, Inc.

Active not recruiting

Colitis, Ulcerative, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡